AISAP Cardio vs CAC Software
AI Verdict
Choose AISAP Cardio if…
Choose AISAP Cardio if you require immediate, comprehensive cardiac diagnostic assessments at the point of care. This tool is ideal for clinicians needing rapid AI-powered interpretation of bedside ultrasound images to quickly detect structural heart disease, heart failure, and various valvular pathologies, integrating seamlessly into existing clinical workflows.
View AISAP Cardio →Choose CAC Software if…
Choose Imbio's CAC Software if your primary need is to quantify coronary artery calcification from existing non-contrast chest CT scans for cardiovascular risk assessment. This solution provides automated, detailed measurements like the Agatston score and 3D visualizations, enabling radiologists and cardiologists to identify and assess coronary artery disease risk non-invasively.
View CAC Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AISAP Cardio | CAC Software |
|---|---|---|
| Pricing | Not publicly available | Contact for pricing |
| Deployment | Cloud-based SaaS platform | Cloud, On-premise, Partner platforms |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AISAP CardioAISAP Cardio is designed for point-of-care ultrasound, enabling rapid, bedside diagnostics and empowering clinicians with basic scanning skills to accurately interpret echocardiograms within minutes. This focus on simplifying complex diagnostic tasks for a broader range of users, including non-cardiologists, highlights a strong emphasis on usability and accessibility in diverse clinical settings.
Clinical Value
AISAP CardioAISAP Cardio offers immediate, comprehensive cardiac diagnostic assessments at the point of care, facilitating early detection of critical conditions like structural heart disease and heart failure. Its ability to empower non-cardiologists to achieve expert-level diagnostic accuracy for acute conditions provides significant clinical value by enabling timely interventions and improving patient outcomes.
Pricing & Value
TieBoth tools lack publicly available pricing information, making a direct comparison of their cost-effectiveness impossible. While both claim to deliver significant value through improved diagnostics, efficiency, and patient outcomes, without transparent pricing, a definitive winner cannot be determined for this dimension.
Enterprise Readiness
CAC SoftwareImbio CAC Software demonstrates superior enterprise readiness through its explicit declaration of HIPAA compliance and Business Associate Agreement (BAA) availability. Furthermore, it offers flexible deployment options including cloud, on-premise, and integration via numerous established partner platforms, indicating a robust and adaptable solution for diverse healthcare IT infrastructures.
Innovation
AISAP CardioAISAP Cardio demonstrates higher innovation by being the first company globally to secure FDA clearance in the CADx pathway for comprehensive structural heart disease diagnosis using point-of-care ultrasound. Its ability to empower clinicians with basic scanning skills to achieve expert-level cardiac diagnoses at the bedside represents a significant advancement in democratizing advanced diagnostics.
Support & Docs
CAC SoftwareImbio CAC Software demonstrates stronger support and documentation by explicitly providing multiple contact channels for customer support, including phone and email, along with a dedicated case submission system and published support hours. Furthermore, it offers a range of user manuals for its products, indicating comprehensive documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AISAP Cardio | CAC Software |
|---|---|---|
| Description | FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. | Automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). |
| Company | Aisap | Imbio |
| Specialties | Cardiology, Emergency Medicine, Radiology. | Cardiology, Radiology |
| Key Features | AI-powered interpretation for early cardiac disease detection, comprehensive cardiac ultrasound software package, automated generation of analyses, interpretations, and reports, assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), measurement of Left Ventricle Ejection Fraction (LVEF), measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter, vendor-agnostic and scalable solution, integration with existing clinical workflows, EHR/EMR, and PACS. | Automated image post-processing for coronary artery calcification, quantification of calcification within coronary arteries, outputs Agatston score, arterial age, calcified lesion mass and volume, provides 3D visualizations and annotated images, non-invasive analysis from non-contrast chest CT scans, integrates into existing DICOM viewing workflow, supports risk assessment for coronary artery disease, deep-learning based analysis. |
Videos
Demos, reviews, and walkthroughs featuring AISAP Cardio and CAC Software.